• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏再同步治疗可能会改善无电或机械不同步的充血性心力衰竭患者的症状。

Cardiac resynchronization therapy may improve symptoms of congestive heart failure in patients without electrical or mechanical dyssynchrony.

作者信息

Nazeri Alireza, Massumi Ali, Rasekh Abdi, Saeed Mohammad, Frank Christopher, Wilson J Michael, Lopez J Alberto, Razavi Mehdi

机构信息

Department of Cardiology, Texas Heart Institute at St Luke's Episcopal Hospital, Houston, 6624 Fannin, Suite 2480, Houston, TX, USA.

出版信息

Europace. 2009 Jan;11(1):86-8. doi: 10.1093/europace/eun326. Epub 2008 Dec 4.

DOI:10.1093/europace/eun326
PMID:19056743
Abstract

AIMS

Cardiac resynchronization therapy (CRT) has reportedly not been effective in the absence of electrical or mechanical dyssynchrony. We present six patients with severe left ventricular (LV) dilation, mitral regurgitation (MR), and non-ischaemic cardiomyopathy who underwent CRT. We assessed the effects of CRT on LV ejection fraction (EF), LV dimensions, mitral valve regurgitant fraction (RF), pulmonary arterial pressures (PAP), and serum levels of B-natriuretic peptide (BNP).

METHODS AND RESULTS

All patients had severe LV dilation (>/=6.8 cm) and no electrical or mechanical dyssynchrony. All patients underwent CRT-D (with defibrillator) without complications. Average echocardiographic follow-up was 4.6 months. Mean LVEF increased significantly from 20.8 +/- 3.4 to 28.3 +/- 2.9% after CRT (P < 0.01). Mean LV end-diastolic dimension decreased significantly from 6.9 +/- 0.15 to 6.45 +/- 0.33 cm after CRT (P = 0.03); mean BNP serum level decreased from 1738 +/- 526 to 1040 +/- 768 pg/mL (P = 0.07). Baseline RF decreased from 45 +/- 12.2 to 20 +/- 10.9% after CRT-D (P = 0.009). Mean PAP decreased from 48.5 +/- 5.8 to 42.6 +/- 5.2 (P = 0.03). In five patients, New York Heart Association class symptoms improved by at least one level. No patients required assist devices or transplantation. One patient was hospitalized during follow-up.

CONCLUSION

We describe six patients with severe LV dilation without evidence of electrical or mechanical dyssynchrony who improved with CRT, possibly due to improvement in MR.

摘要

目的

据报道,在不存在电或机械不同步的情况下,心脏再同步治疗(CRT)无效。我们报告了6例患有严重左心室(LV)扩张、二尖瓣反流(MR)和非缺血性心肌病的患者接受了CRT治疗。我们评估了CRT对左心室射血分数(EF)、左心室尺寸、二尖瓣反流分数(RF)、肺动脉压(PAP)和B型利钠肽(BNP)血清水平的影响。

方法与结果

所有患者均有严重的左心室扩张(≥6.8 cm),且无电或机械不同步。所有患者均接受了CRT-D(带除颤器)治疗,无并发症发生。平均超声心动图随访时间为4.6个月。CRT治疗后,平均左心室射血分数从20.8±3.4显著增加至28.3±2.9%(P<0.01)。CRT治疗后,平均左心室舒张末期内径从6.9±0.15显著减小至6.45±0.33 cm(P = 0.03);平均BNP血清水平从1738±526降至1040±768 pg/mL(P = 0.07)。CRT-D治疗后,基线反流分数从45±12.2降至20±10.9%(P = 0.009)。平均肺动脉压从48.5±5.8降至42.6±5.2(P = 0.03)。5例患者的纽约心脏协会心功能分级症状改善至少一级。无患者需要辅助装置或进行移植。1例患者在随访期间住院。

结论

我们描述了6例严重左心室扩张且无电或机械不同步证据的患者,他们通过CRT治疗得到改善,可能是由于二尖瓣反流得到改善。

相似文献

1
Cardiac resynchronization therapy may improve symptoms of congestive heart failure in patients without electrical or mechanical dyssynchrony.心脏再同步治疗可能会改善无电或机械不同步的充血性心力衰竭患者的症状。
Europace. 2009 Jan;11(1):86-8. doi: 10.1093/europace/eun326. Epub 2008 Dec 4.
2
Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.晚期依赖血管活性药物的IV级心力衰竭患者的心脏再同步治疗
Am J Cardiol. 2007 Jul 1;100(1):90-3. doi: 10.1016/j.amjcard.2007.02.058. Epub 2007 May 15.
3
Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance.心脏再同步治疗对运动诱发二尖瓣反流的早期和晚期影响:与左心室不同步、重构及心肺功能的关系
Eur Heart J. 2007 Sep;28(17):2134-41. doi: 10.1093/eurheartj/ehm126. Epub 2007 May 15.
4
Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.缺血性或非缺血性心肌病所致收缩期左心室功能障碍及轻度心力衰竭症状患者的心脏再同步治疗
Am J Cardiol. 2006 Jul 15;98(2):230-5. doi: 10.1016/j.amjcard.2006.01.080. Epub 2006 May 19.
5
Effect of cardiac resynchronization therapy in isolated ventricular noncompaction in adults: follow-up of four cases.心脏再同步治疗对成人孤立性心室心肌致密化不全的疗效:4例随访
J Cardiovasc Electrophysiol. 2008 Sep;19(9):935-8. doi: 10.1111/j.1540-8167.2008.01161.x. Epub 2008 Apr 9.
6
Predictors of response to cardiac resynchronization therapy--importance of left ventricular dyssynchrony.心脏再同步治疗反应的预测因素——左心室不同步的重要性。
Rev Port Cardiol. 2006 Jun;25(6):569-81.
7
Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation.心脏再同步治疗对功能性二尖瓣反流的长期影响。
Am J Cardiol. 2009 Aug 1;104(3):383-8. doi: 10.1016/j.amjcard.2009.03.060. Epub 2009 Jun 6.
8
Effect of cardiac resynchronization therapy in patients with moderate left ventricular systolic dysfunction and wide QRS complex: a prospective study.心脏再同步治疗对中度左心室收缩功能不全及QRS波增宽患者的影响:一项前瞻性研究。
J Cardiovasc Electrophysiol. 2006 Dec;17(12):1288-92. doi: 10.1111/j.1540-8167.2006.00612.x. Epub 2006 Sep 20.
9
Cardiac contractility modulation in non-responders to cardiac resynchronization therapy.心脏再同步治疗无反应者的心脏收缩力调制
Europace. 2008 Dec;10(12):1375-80. doi: 10.1093/europace/eun257. Epub 2008 Sep 5.
10
Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.心脏再同步治疗对无症状或轻度症状性左心室功能不全患者疾病进展的预防作用:来自欧洲队列的REVERSE(收缩期左心室功能不全再同步逆转重塑)试验的见解
J Am Coll Cardiol. 2009 Nov 10;54(20):1837-46. doi: 10.1016/j.jacc.2009.08.011. Epub 2009 Oct 1.